Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D Immunomodulation in Hemodialysis
NCT00686751Phase 2Completed
- Sponsor
- Fresenius
- Start
- Dec 2004
- Primary completion
- Sep 2007
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of paricalcitol in end stage renal disease (ESRD), sponsored by Fresenius. Started Dec 2004; status: completed.
02
Drugs
paricalcitol
03
Conditions
end stage renal disease (ESRD)
Beyond the preview
Go deeper on NCT00686751.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00686751.